126 related articles for article (PubMed ID: 2777412)
21. Where pathology meets molecular biology: N-myc amplification in human neuroblastoma as a paradigm for the clinical use of an oncogene alteration.
Schwab M
Verh Dtsch Ges Pathol; 1994; 78():26-33. PubMed ID: 7533996
[TBL] [Abstract][Full Text] [Related]
22. Patterns of regulation of nuclear proto-oncogenes MYCN and MYB in retinoic acid treated neuroblastoma cells.
Thiele CJ
Prog Clin Biol Res; 1991; 366():151-6. PubMed ID: 2068135
[No Abstract] [Full Text] [Related]
23. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma.
Bordow SB; Haber M; Madafiglio J; Cheung B; Marshall GM; Norris MD
Cancer Res; 1994 Oct; 54(19):5036-40. PubMed ID: 7923112
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts.
Vassal G; Terrier-Lacombe MJ; Bissery MC; Vénuat AM; Gyergyay F; Bénard J; Morizet J; Boland I; Ardouin P; Bressac-de-Paillerets B; Gouyette A
Br J Cancer; 1996 Aug; 74(4):537-45. PubMed ID: 8761367
[TBL] [Abstract][Full Text] [Related]
25. S-cells from a highly N-myc-amplified neuroblastoma are tumorigenic in nude mice.
Sleight BJ; Soukup S; Ballard ET; Parysek LM
Anticancer Res; 1993; 13(6A):2031-6. PubMed ID: 8297111
[TBL] [Abstract][Full Text] [Related]
26. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma.
Thiele CJ; Reynolds CP; Israel MA
Nature; 1985 Jan 31-Feb 6; 313(6001):404-6. PubMed ID: 3855502
[TBL] [Abstract][Full Text] [Related]
27. [Tumor cytogenetics and prognosis in neuroblastoma].
Christiansen H; Lampert F
Monatsschr Kinderheilkd; 1989 Oct; 137(10):666-71. PubMed ID: 2586532
[TBL] [Abstract][Full Text] [Related]
28. Interferon-gamma cooperates with retinoic acid and phorbol ester to induce differentiation and growth inhibition of human neuroblastoma cells.
Guzhova I; Hultquist A; Cetinkaya C; Nilsson K; Påhlman S; Larsson LG
Int J Cancer; 2001 Oct; 94(1):97-108. PubMed ID: 11668484
[TBL] [Abstract][Full Text] [Related]
29. N-myc amplification in multiple homogeneously staining regions in two human neuroblastomas.
Emanuel BS; Balaban G; Boyd JP; Grossman A; Negishi M; Parmiter A; Glick MC
Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3736-40. PubMed ID: 2582423
[TBL] [Abstract][Full Text] [Related]
30. MYCN amplification and 17q in neuroblastoma: evidence for structural association.
O'Neill S; Ekstrom L; Lastowska M; Roberts P; Brodeur GM; Kees UR; Schwab M; Bown N
Genes Chromosomes Cancer; 2001 Jan; 30(1):87-90. PubMed ID: 11107180
[TBL] [Abstract][Full Text] [Related]
31. Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene.
Yanagihara K; Seyama T; Tsumuraya M; Kamada N; Yokoro K
Cancer Res; 1991 Jan; 51(1):381-6. PubMed ID: 1846312
[TBL] [Abstract][Full Text] [Related]
32. Amplification of N-myc and ornithine decarboxylase genes in human neuroblastoma and hydroxyurea-resistant hamster cell lines.
Tonin PN; Yeger H; Stallings RL; Srinivasan PR; Lewis WH
Oncogene; 1989 Sep; 4(9):1117-21. PubMed ID: 2780050
[TBL] [Abstract][Full Text] [Related]
33. A new human highly tumorigenic neuroblastoma cell line with undetectable expression of N-myc.
Cornaglia-Ferraris P; Ponzoni M; Montaldo P; Mariottini GL; Donti E; Di Martino D; Tonini GP
Pediatr Res; 1990 Jan; 27(1):1-6. PubMed ID: 2296463
[TBL] [Abstract][Full Text] [Related]
34. Establishment and characterization of five human small cell lung cancer cell lines from early tumor xenografts.
Arvelo F; Poupon MF; Le Chevalier T
Anticancer Res; 1994; 14(5A):1893-901. PubMed ID: 7847823
[TBL] [Abstract][Full Text] [Related]
35. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.
Hanada M; Krajewski S; Tanaka S; Cazals-Hatem D; Spengler BA; Ross RA; Biedler JL; Reed JC
Cancer Res; 1993 Oct; 53(20):4978-86. PubMed ID: 8402688
[TBL] [Abstract][Full Text] [Related]
36. A neuroblastoma cell line derived from a case detected through a mass screening system in Japan: a case report including the biologic and phenotypic characteristics of the cell line.
Hiraiwa H; Hamazaki M; Takata A; Kikuchi H; Hata J
Cancer; 1997 May; 79(10):2036-44. PubMed ID: 9149033
[TBL] [Abstract][Full Text] [Related]
37. Newly-derived neuroblastoma cell lines propagated in serum-free media recapitulate the genotype and phenotype of primary neuroblastoma tumours.
Bate-Eya LT; Ebus ME; Koster J; den Hartog IJ; Zwijnenburg DA; Schild L; van der Ploeg I; Dolman ME; Caron HN; Versteeg R; Molenaar JJ
Eur J Cancer; 2014 Feb; 50(3):628-37. PubMed ID: 24321263
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of N-myc in phenotypically distinct subclones of a human neuroblastoma cell line.
Foley J; Cohn SL; Salwen HR; Chagnovich D; Cowan J; Mason KL; Parysek LM
Cancer Res; 1991 Dec; 51(23 Pt 1):6338-45. PubMed ID: 1933896
[TBL] [Abstract][Full Text] [Related]
39. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line.
Chambéry D; Mohseni-Zadeh S; de Gallé B; Babajko S
Cancer Res; 1999 Jun; 59(12):2898-902. PubMed ID: 10383152
[TBL] [Abstract][Full Text] [Related]
40. Proto-oncogene abnormalities and their relationship to tumorigenicity in some human glioblastomas.
U HS; Kelley PY; Hatton JD; Shew JY
J Neurosurg; 1989 Jul; 71(1):83-90. PubMed ID: 2738645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
